- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04875013
Interactive Rehabilitation for Adults With Unilateral Vestibular Weakness
Efficacy of Vestibular Rehabilitation Using Computerized Dynamic Posturography With Virtual Reality for Stable Unilateral Vestibular Weakness
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
North Vancouver, British Columbia, Canada, V7M 2H5
- Dr. EA David MD FRCSC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult Age 18-80
Unilateral vestibular weakness confirmed one or more of:
- Videonystagmography
- VEMP
- Or unilateral vestibular weakness idiopathic, not yet diagnosed (NYD)
- Persistent imbalance following diagnosis of resolved benign paroxysmal positional vertigo (BPPV)
- Symptomatic
- Long-standing/persistent symptoms greater than one year
Exclusion Criteria:
- Orthopedic deficit (eg. lower body joint dysfunction or lower joint replacement)
- Neurological deficit or proprioception deficit
- Diabetes
- Poor vision or blindness
- Fluctuating vestibular symptoms, or condition known to fluctuate eg. Menière's disease, perilymphatic fistula (PLF) or superior canal deshicsence (SDCS)
- Active benign paroxysmal positional vertigo (BPPV)
- Undergoing treatment which may affect balance or ability to stand
- Cognitive impairment that prevents understanding and responding to instructions required to complete the study
- Inability to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vestibular rehabilitation with dynamic posturography
12 sessions, twice per week, of rehabilitation exercises last about 20 minutes, using CDP and interactive visual feedback
|
Rehabilitation exercises guided by an interactive display and measured by a footplate sensor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Sensory Organization Test (SOT) Composite Score (Score After Retraining Minus Score at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in composite score of Sensory Organization Test (SOT) (Scores from 0-100; higher scores indicate better function); Lower scores indicate larger amount of sway Calculated as a composite of the 6 individual conditions of the SOT:
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Dizziness Handicap Inventory Score (Score After Retraining Minus Score at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Dizziness Handicap Inventory (DHI); scale from 0-100; higher scores indicate greater disability; 16-34 Points (mild handicap), 36-52 Points (moderate handicap), 54+ Points (severe handicap)
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Activities-specific Balance Confidence Scale Score (Score After Retraining Minus Score at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Activities-specific Balance Confidence (ABC) score; (Scores from 0-100; higher scores indicate greater confidence in performing activities of daily living)
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Fall Efficacy Scale-International (FES-I) (Score After Retraining Minus Score at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Fall Efficacy Scale-International (FES-I); possible scores 16-64, higher score indicates greater perceived fall risk
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Limits of Stability Area (Area After Retraining Minus Area at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in endpoint excursion and maximum excursion functional stability region area, calculated from Limits of Stability (LOS) score Higher score indicates an ability to volitionally lean to larger angles. 100% of theoretical maximum in all directions would give an area of 28284. LOS excursion scores were calculated by the instrument software, from which we calculated the area of the endpoint excursion functional stability region (the sum of areas between adjacent Endpoint Excursion limits) and the area of the maximum excursion functional stability region (the sum of areas between adjacent Maximum Excursion limits) using published methods (Alvarez-Otero R, Perez-Fernandez N. The limits of stability in patients with unilateral vestibulopathy. Acta Oto-laryngol. 2017;137(10):1-6. doi:10.1080/00016489.2017.1339326) |
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Sensory Organization Test Scores for Conditions 1 to 6 (Scores After Retraining Minus Scores at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in mean Sensory Organization Test Scores for conditions 1 through 6; (Scores from 0-100; higher scores indicate better function) The 6 conditions are:
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Sensory Organization Test Vestibular Contribution (Ratio After Retraining Minus Ratio at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in mean value of Sensory Organization Test condition 5/mean value of SOT conditions 1; measured as a ratio, higher scores indicate a greater vestibular contribution to balance deficit
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Limits of Stability Directional Control Component (Score After Retraining Minus Score at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Limits of Stability test mean value of directional control of limits of stability; (Scores from 0-100; higher scores indicate better function)
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Change in Endpoint and Maximum Excursion Values From Limits of Stability Test (Score After Retraining Minus Score at Baseline)
Time Frame: Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Limits of Stability test mean endpoint excursion value and maximum excursion point; (Scores from 0-100; higher scores indicate better function)
|
Through study completion, 12 rehabilitation sessions, an average of 7 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to Rehabilitation Protocol
Time Frame: Through study completion, maximum of 12 weeks
|
Percentage of subjects that complete 12 sessions
|
Through study completion, maximum of 12 weeks
|
Missed Sessions
Time Frame: Through study completion, maximum of 12 weeks
|
Mean number of missed and rescheduled rehabilitation sessions
|
Through study completion, maximum of 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eytan David, MD, University of British Columbia
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H20-04045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dizziness
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonCompletedVestibular Disease | Chronic Dizziness | Persistent Postural Perceptual DizzinessUnited Kingdom
-
Hospital Clinico Universitario de SantiagoInstituto de Salud Carlos III; European Regional Development FundUnknownFall | Dizziness ChronicSpain
-
Hospital Clinico Universitario de SantiagoInstituto de Salud Carlos III; European Regional Development FundCompletedFall | Elderly | Dizziness Chronic
-
University Hospital, CaenRecruiting
-
University of JordanCompletedVestibular DizzinessJordan
-
Kyunghee UniversityWithdrawn
-
Ludwig-Maximilians - University of MunichCompletedVertigo | Bilateral Vestibulopathy | Functional DizzinessGermany
-
Zhan YunfanRecruitingCervicogenic DizzinessChina
-
Guy's and St Thomas' NHS Foundation TrustWithdrawnVestibular Disease | Chronic DizzinessUnited Kingdom
-
Korea Health Industry Development InstituteTerminatedChronic Subjective DizzinessKorea, Republic of
Clinical Trials on Vestibular rehabilitation with dynamic posturography
-
Eytan A. DavidActive, not recruitingDizziness | Equilibrium; Disorder, Labyrinth | Inner Ear Injury | Inner Ear DiseaseCanada
-
University Hospital, MontpellierCompletedVestibular Syndrome | Optokinetic StimulationFrance
-
Hospital Clinico Universitario de SantiagoInstituto de Salud Carlos III; European Regional Development FundCompletedFall | Elderly | Dizziness Chronic
-
National Cheng Kung UniversityRecruiting
-
Central Hospital, Nancy, FranceUniversity of LorraineUnknown
-
University of British ColumbiaNot yet recruitingLabyrinthitis | Benign Paroxysmal Positional Vertigo | Vestibular Neuronitis | Meniere Disease | Vestibular Neuritis | Herpes Zoster Oticus | Peripheral Vestibular Disorder
-
Gødstrup HospitalNot yet recruitingChildren, Only | Development Delay | Vestibular Disorder | Vestibular Function Disorder
-
Gødstrup HospitalNot yet recruitingSensorineural Hearing Loss | Children, Only | Vestibular Disorder | Vestibular Function
-
Gødstrup HospitalNot yet recruitingChildren, Only | Vestibular Function
-
Pamukkale UniversityUnknownDizziness | Virtual Reality | Vestibular RehabilitationTurkey